| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 5 | 2/13/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $167,400 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 5 | 7/28/2022 | NON-COMPETING CONTINUATION | $167,400 |
|
| Issue Date FY: 2021 ( Subtotal = $167,400 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 7/26/2021 | NON-COMPETING CONTINUATION | $167,400 |
|
| Issue Date FY: 2020 ( Subtotal = $167,400 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 7/27/2020 | NON-COMPETING CONTINUATION | $167,400 |
|
| Issue Date FY: 2019 ( Subtotal = $167,400 ) |
| 2019 | 2019 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 7/24/2019 | NON-COMPETING CONTINUATION | $167,400 |
|
| Issue Date FY: 2018 ( Subtotal = $168,900 ) |
| 2018 | 2018 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 8/30/2018 | NEW | $168,900 |
|
|